Eligibility Prostate Cancer NCT00585416

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
metastatic hormone refractory prostate cancer.
Beskrivning

metastatic hormone refractory prostate cancer

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0936223
UMLS CUI [1,2]
C1328504
eastern cooperative oncology group (ecog) performance status of 0-1.
Beskrivning

ecog

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
testosterone <50ng/dl. patients must continue primary androgen deprivation with an lhrh analogue if they have not undergone orchiectomy.
Beskrivning

testosterone, androgen deprivation

Datatyp

boolean

Alias
UMLS CUI [1]
C0039601
UMLS CUI [2]
C0279492
progressive disease after androgen deprivation.
Beskrivning

disease progression after androgen deprivation

Datatyp

boolean

Alias
UMLS CUI [1]
C1328504
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients whose clinical condition would make chemotherapy clearly indicated.
Beskrivning

chemotherapy indicated by patient condition

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1444656
UMLS CUI [1,3]
C0683521
patients who have received systemic chemotherapy for the treatment of metastatic disease.
Beskrivning

systemic chemotherapy for metastatic disease

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1883256
UMLS CUI [1,2]
C0027627
peripheral neuropathy > grade 1
Beskrivning

peripheral neuropathy

Datatyp

boolean

Alias
UMLS CUI [1]
C0031117
prior anti-angiogenic therapy, including thalidomide.
Beskrivning

anti-angiogenic therapy

Datatyp

boolean

Alias
UMLS CUI [1]
C0596087
patients with inadequate recovery from any prior surgical procedure, or patients having undergone any major surgical procedure or radiation within 4 weeks prior to study entry.
Beskrivning

surgery recovery, prior major surgery or radiation

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C2004454
UMLS CUI [2]
C0679637
UMLS CUI [3]
C1522449
patients who have received radiopharmaceuticals (strontium, samarium) within 8 weeks prior to enrollment.
Beskrivning

radiopharmaceuticals

Datatyp

boolean

Alias
UMLS CUI [1]
C0182638
patients with known brain metastases or history of brain metastases.
Beskrivning

brain metastasis

Datatyp

boolean

Alias
UMLS CUI [1]
C0220650
history of stroke within 6 months of treatment or other significant neurological limitations.
Beskrivning

surgery recovery, neurological limitations

Datatyp

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0027765
patients who have received more than 2 prior investigational treatments.
Beskrivning

investigational treatment

Datatyp

boolean

Alias
UMLS CUI [1]
C0949266
uncontrolled intercurrent illness
Beskrivning

comorbidities

Datatyp

boolean

Alias
UMLS CUI [1]
C0009488
patients with a history of a myocardial infarction within the prior 6 months or, hospitalizations for decompensated congestive heart failure within the prior 6 months, or history of significant / symptomatic cardiac arrhythmias
Beskrivning

myocardial infarction, hospitalizations for congestive heart failure, cardiac arrhythmias

Datatyp

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2,1]
C0018802
UMLS CUI [2,2]
C0019993
UMLS CUI [3]
C0003811

Similar models

Eligibility Prostate Cancer NCT00585416

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
metastatic hormone refractory prostate cancer
Item
metastatic hormone refractory prostate cancer.
boolean
C0936223 (UMLS CUI [1,1])
C1328504 (UMLS CUI [1,2])
ecog
Item
eastern cooperative oncology group (ecog) performance status of 0-1.
boolean
C1520224 (UMLS CUI [1])
testosterone, androgen deprivation
Item
testosterone <50ng/dl. patients must continue primary androgen deprivation with an lhrh analogue if they have not undergone orchiectomy.
boolean
C0039601 (UMLS CUI [1])
C0279492 (UMLS CUI [2])
disease progression after androgen deprivation
Item
progressive disease after androgen deprivation.
boolean
C1328504 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
chemotherapy indicated by patient condition
Item
patients whose clinical condition would make chemotherapy clearly indicated.
boolean
C0392920 (UMLS CUI [1,1])
C1444656 (UMLS CUI [1,2])
C0683521 (UMLS CUI [1,3])
systemic chemotherapy for metastatic disease
Item
patients who have received systemic chemotherapy for the treatment of metastatic disease.
boolean
C1883256 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
peripheral neuropathy
Item
peripheral neuropathy > grade 1
boolean
C0031117 (UMLS CUI [1])
anti-angiogenic therapy
Item
prior anti-angiogenic therapy, including thalidomide.
boolean
C0596087 (UMLS CUI [1])
surgery recovery, prior major surgery or radiation
Item
patients with inadequate recovery from any prior surgical procedure, or patients having undergone any major surgical procedure or radiation within 4 weeks prior to study entry.
boolean
C0543467 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
C0679637 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
radiopharmaceuticals
Item
patients who have received radiopharmaceuticals (strontium, samarium) within 8 weeks prior to enrollment.
boolean
C0182638 (UMLS CUI [1])
brain metastasis
Item
patients with known brain metastases or history of brain metastases.
boolean
C0220650 (UMLS CUI [1])
surgery recovery, neurological limitations
Item
history of stroke within 6 months of treatment or other significant neurological limitations.
boolean
C0038454 (UMLS CUI [1])
C0027765 (UMLS CUI [2])
investigational treatment
Item
patients who have received more than 2 prior investigational treatments.
boolean
C0949266 (UMLS CUI [1])
comorbidities
Item
uncontrolled intercurrent illness
boolean
C0009488 (UMLS CUI [1])
myocardial infarction, hospitalizations for congestive heart failure, cardiac arrhythmias
Item
patients with a history of a myocardial infarction within the prior 6 months or, hospitalizations for decompensated congestive heart failure within the prior 6 months, or history of significant / symptomatic cardiac arrhythmias
boolean
C0027051 (UMLS CUI [1])
C0018802 (UMLS CUI [2,1])
C0019993 (UMLS CUI [2,2])
C0003811 (UMLS CUI [3])